MedPath

Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients

Not Applicable
Recruiting
Conditions
Critical Illness Myopathy
Interventions
Device: Neuromuscular electrical stimulation
Other: Sham
Registration Number
NCT03083652
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

Neuromuscular electrical stimulation (NMES) implemented during the intensive care unit(ICU) stay may improve exercise capacity and prevent muscular weakness in critically ill patients with respiratory disease. Main objective: To evaluate, in respiratory critically ill patients, the effects of a conventional physiotherapy program with or without additional NMES applied only during the ICU stay on exercise capacity. Design: Randomized, controlled, double-blind clinical trial on patients (\>18yo) with diagnosis on admission of acute or acute on chronic respiratory disease, on mechanical ventilation (MV) \> 72h and expected MV \> 24h. Intervention: Conventional physiotherapy with or without 30-minutes (5days/week) on quadriceps femoris and gluteus maximus. Patients in the control group will follow the same protocol but the device will not be activated. Measures: Demographic data, body composition through bioelectrical impedance analysis (BIA), and functional capacity before admission through Barthel scale will be registered upon inclusion. Exercise capacity through test sit-to stand, muscular strength through Medical Research Council (MRC) score and dynamometry, body composition through BIA, and functional capacity through Barthel scale will be obtained at ICU and hospital discharge.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Diagnosis at admission: acute or acute on chronic respiratory disease
  • Mechanical ventilation > 72h at inclusion
  • Expected mechanical ventilation > 24h
  • Informed consent
Exclusion Criteria
  • Patients re-admitted to ICU (no hospital discharge)
  • Exitus or transfer to another service/hospital
  • Respiratory instability [Inspired fraction of oxygen (FIO2) >60% or positive end-expiratory pressure (PEEP) >10 cmH2O] and/or hemodynamic instability [Mean arterial pressure ( MAP)<60mmHg although vasoactive drugs] during > 24h.
  • Pregnancy
  • Neuromuscular disease before admission
  • Skin lesions
  • Limitation of therapeutic effort
  • Mental and/or physical limitation to understand/realize tests for evaluation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionNeuromuscular electrical stimulationConventional physiotherapy with daily 30-minutes NMEs (5 days/week)
ControlShamConventional physiotherapy with NMEs device not activated
Primary Outcome Measures
NameTimeMethod
Exercise capacity24h before hospital discharge

Test sit-to-stand

Secondary Outcome Measures
NameTimeMethod
Muscle strength24h before hospital discharge

MRC score and dynamometry

Body composition (fat free mass)24h before hospital discharge

Bioelectrical impedance

Functional Capacity24h before hospital discharge

Barthel scale

Trial Locations

Locations (1)

Unidad de Vigilancia Intensiva Respiratoria (UVIR)

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath